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What is e-Cigarette and 
Associated Health Risks
Narendra Maddu
Abstract
Tobacco is consumed in two forms named as smoking and smokeless tobacco. The 
electronic cigarettes are under the form of smoking tobacco. The electronic cigarettes 
(e-cigarettes) exposure has increased in recent years to the market. Many e-cigarettes 
contain nicotine, the primary most addictive agent in all tobacco products. We 
investigated the relationship between e-cigarettes and human health risks. These 
products may deliver sufficient nicotine for physiological responses and affects the all 
organs and tissues like nervous, cardiovascular, and pulmonary systems by exhibiting 
the effects of cytotoxic, decrease in heart rate, and extensive pulmonary damage. The 
e-cigarettes cannot be regarded as safe even though they are less harmful.
Keywords: electronic cigarettes, human health risks, smoking tobacco, e-cigarettes, 
nicotine
1. Introduction
The concept of the electronic cigarettes (EC) is quite old. It is developed in 1963 
by Herbert Gilbert with a license under the name of smokeless non-tobacco ciga-
rette. The device was first commercialized in China under the auspices of the Golden 
Dragon holdings. The technology of vaporization through a heating resistance was 
developed in 2009, and commercialized as an (ENDS) electronic nicotine delivery 
system [1]. EC also known as e-cigarettes, have become a popular alternative to 
cigarettes. The appearance of vaporized nicotine products widely referred to as 
electronic cigarettes or e-cigarettes (EC) has provided consumers with an alternative 
means of nicotine intake [2]. Information in this book has been taken from repre-
sentatives of the Ministry of Health’s or other regulatory body’s verifications in the 
respective countries. There are 83 countries that have national/federal laws regulat-
ing e-cigarettes including laws related to the sale, age, advertisement, promotion, 
sponsorship, packaging with concern to health warning labeling and trademark, 
product regulation corresponding to nicotine concentration, safety, ingredients and 
flavors reporting taxation, use types and its toxicological evidences of e-cigarettes. 
Nicotine is not a carcinogenic agent, but it is a powerfully addictive substance.
The modern e-cigarette was invented in 2003 by Chinese pharmacist Hon Lik 
and as of 2018 most e-cigarettes are made in China [3]. Since they were first sold 
in 2004 their global use has risen exponentially [4]. In the United States and the 
United Kingdom their use is widespread. Reasons for using e-cigarettes involve try-
ing to quit smoking, reduce risk, or save money, though some use them recreation-
ally [5]. There are around 500 brands of e-cigarettes, with global sales in excess of 
US $ 7 billion [6].
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2. What is e-cigarette?
The appearance of vaporized nicotine products widely referred to as e-cigarettes 
(EC) has provided consumers with an alternative means of nicotine intake [2]. An 
electronic cigarette or e-cigarette is also known as e-cigs, electronic nicotine deliv-
ery systems (ENDS) or electronic non-nicotine delivery systems (ENNDS), elec-
tronic smoking devices (ESDs), personal vaporizers (PVs), is a handheld electronic 
device that simulates the feeling of smoking. It works by heating a liquid to generate 
an aerosol, commonly called a “vapor”, that the user inhales [4]. Using e-cigarettes 
is commonly referred to as vaping. The liquid in the e-cigarette, called e-liquid, or 
e-juice, is usually made of nicotine, propylene glycol, glycerine, and flavorings. Not 
all e-liquids contain nicotine. Most e-cigarettes contain a liquid, known as e-liquid 
or e-juice that contains a mixture of the following:
Water
Propylene glycol (PG)
Vegetable glycerin (VG)
Flavouring
Nicotine.
Different strengths of nicotine are available. The best way to assess the strength 
is by looking at the concentration which is expressed as milligrams of nicotine per 
millilitre of liquid (mg/ml), or a percentage (Table 1).
3. Construction of e-cigars
An electronic cigarette is a battery-powered vaporizer [7]. The primary parts 
that make up an e-cigarette are a mouthpiece, a cartridge, a heating element/
atomizer, a microprocessor, a battery, and possibly a LED light on the end. An 
atomizer comprises a small heating element that vaporizes e-liquid and wicking 
material that draws liquid onto the coil. When the user pushes a button, or (in 
some variations) activates a pressure sensor by inhaling, the heating element 
then atomizes the liquid solution. The e-liquid reaches a temperature of roughly 
100–250°C (212–482°F) within a chamber to create an aerosolized vapor. The 
user inhales the aerosol, commonly called vapor, rather than cigarette smoke. The 
aerosol provides a flavor and feels similar to tobacco smoking. There are three 
main types of e-cigarettes:
1. cigalikes, looking like cigarettes;
2. eGos, bigger than cigalikes with refillable liquid tanks and;
3. mods, assembled with basic parts or by altering existing products.
S. no Strength mg/ml Percentage (%)
1 Nicotine free 0.0 0
2 Low 8.0 0.8
3 Medium 12.0 1.2
4 High 24.0 2.4
5 Highest 36.0 3.6
Table 1. 
Different concentration/percentage of e-cigarettes.
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First generation e-cigarettes tend to look like tobacco cigarettes and so are called 
“cigalikes” [8]. Most cigalikes look like cigarettes but there is some variation in size. 
Second generation devices are larger overall and look less like tobacco cigarettes. 
Third generation devices include mechanical mods and variable voltage  
devices. The fourth generation includes sub ohm tanks and temperature control 
devices. The power source is the biggest component of an e-cigarette, which is 
frequently a rechargeable lithium-ion battery [3] (Figures 1 and 2).
The majority of toxic chemicals found in tobacco smoke are absent in e-cigarette 
aerosol [9]. Those present are mostly below 1% of the corresponding levels in 
tobacco smoke. e-Cigarettes create an aerosol that can contain toxicants and traces 
Figure 1. 
Structure of e-cigar.
Figure 2. 
Types of e-cigs.
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of heavy metals at levels permissible in inhalation medicines [4] and potentially 
harmful chemicals not found in tobacco smoke at concentrations permissible by 
workplace safety standards.
4. Content of e-liquid
The liquid is composed of carrier solvents in e-cigarette, such as glycerol and/
or propylene glycol. Aerosol generated from an e-cigarette is commonly but inac-
curately referred to as ‘vapour’. Vapour refers to the gaseous state of a substance; 
in contrast, an aerosol is a suspension of fine particles of liquid, solid or both in 
a gas form. Both the particulate and gases phase are mixtures of chemical sub-
stances in e-cigarette aerosols. The e-cigarette aerosol simulates cigarette smoke 
[10]. A puff of the aerosol is delivered into the user’s mouth and lungs through 
inhalation, after which the remaining aerosol is exhaled into the environment 
[11]. These products are commercialised in various forms or ‘models’ with differ-
ent design characteristics and generate different physical and chemical character-
istics during operation.
e-cigarettes are becoming ever more popular, a concerning trend given 
limited information about their research. Marketers of e-cigarettes have made a 
variety of claims indicating that e-cigarettes are safer than conventional ciga-
rettes and that their use facilitates smoking cessation [12]. However, e-cigarette 
manufacturers do not provide complete information on the chemicals used in 
the manufacturing process or the chemicals that may be released or synthesized 
during the aerosol generation process that occurs during use. Minimal valid 
research data are available on e-cigarette emissions. Furthermore, nicotine lev-
els are intentionally formulated to create target strengths, yet measured levels 
may not match the label claim [13]. Consequently, safety concerns exist regard-
ing e-cigarette user exposure to harmful and potentially harmful constituents 
(HPHCs), including nicotine, which has the potential to cause addiction and 
other adverse events [14].
5. Harmful chemicals in electronic cigarettes
While a limited numbers of studies have been conducted on EC to date, scien-
tific studies have been identified hundreds of chemicals in the vapors of EC. About 
42 chemicals are identified in the ECs, among which main stream smoke exposure 
can be especially harmful to health and some are emitted in the second hand smoke. 
They are listed in Table 2.
Main stream smoke Second hand smoke
Acetaldehyde and acetone Benzene
Acrolein Farmaldehyde and benzaldehyde
Cadmium, nickle and lead Diethylene glycol
Chromium Nicotine and N-nitrosonornicotine
Phenol and propylene glycol
O-methylbenzaldehyde
Table 2. 
Chemicals in e-cigarettes.
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6. Frequency of e-cig users in global world
When the FDA commissioned their 2018 report on ENDS which they label as a 
Tobacco Product, the authors chose to use the term e-cigarettes for some use e-juice 
without nicotine [15]. At least 52% of smokers or ex-smokers in one area have vaped 
[16]. In the US, as of 2014, 12.6% of adults had used an e-cigarette at least once and 
approximately 3.7% were still using them [6], 1.1% of adults were daily users. Non-
smokers and former smokers who had quit more than 4 years earlier were extremely 
unlikely to be current users [17]. In the UK, there were about 2.6 million users in 
2015 which is about 18% of current smokers and about 5% of the population. About 
59% of current smokers said they had tried them. In France in 2014, between 7.7 
and 9.2 million people have tried e-cigarettes and 1.1–1.9 million use them on a daily 
basis. About 67% of French smokers use e-cigarettes to reduce or quit smoking. 
French people who have tried e-cigarettes, 9% have never smoked tobacco. Of the 
1.2% who had recently stopped tobacco smoking at the time of the survey, 84% 
credited e-cigarettes as essential in quitting.
Although smoking among young people has declined over the last 5 years, this 
has coincided with a growth in the use of alternative nicotine products [18]. Some 
young people who have tried an e-cigarette have never smoked tobacco, so vaping can 
be a starting point for nicotine use [19]. The evidence on whether e-cigarettes are a 
gateway to tobacco smoking in later life is mixed and contradictory. e-Cigarettes, also 
known as vape pens, cartridges and pens, differ from traditional marijuana cigarettes 
in several respects. e-Cigarettes may be used with other substances and cartridges 
can potentially be filled with e-liquid containing substances other than nicotine, thus 
serving as a new way to deliver other psychoactive drugs, for example THC [20].
The amount of nicotine found in 13 inhalations from an e-cigarette with fluid 
containing 18 mg/ml nicotine was estimated to be equivalent to the amount found in a 
typical tobacco cigarette containing 0.5 mg nicotine [21]. Most medical organizations, 
including international organizations such as the WHO and those in the US, feel there 
is insufficient evidence to routinely recommend electronic cigarettes for use in smoking 
cessation [4] other medical organizations, particularly British ones, state e-cigarettes 
are a reasonable third-best alternative for smokers who are unable to quit. The available 
research on e-cigarette use for smoking cessation is limited. Some medical authorities 
recommend that e-cigarettes have a role in smoking cessation, and others disagree.
A 2016 meta-analysis based on 20 different studies found that smokers who 
vaped were 28% less likely to quit than those who had not tried electronic ciga-
rettes. In the US, e-cigarettes have not been subject to the same efficacy testing as 
nicotine replacement products. Several authorities, including the World Health 
Organization, feel there is not enough evidence to recommend e-cigarettes for quit-
ting smoking, and there are studies showing a decline in smoking cessation among 
dual users [22, 23]. Nicotine-containing e-cigarettes were associated with greater 
effectiveness for quitting smoking than e-cigarettes without nicotine. e-Cigarettes 
without nicotine may reduce tobacco cravings because of the smoking-related 
physical stimuli.
7. Adverse effects of vaping
The health risks of e-cigarettes are uncertain. Their long-term health effects are 
not known. When used by non-smokers, e-cigarettes can lead to nicotine addiction, 
and there is concern that children could start smoking after using e-cigarettes. So 
far, no serious adverse effects have been reported in trials. Less serious adverse 
effects include throat and mouth irritation, vomiting, nausea, and coughing.  
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The European Commission recently concluded that the use of refillable electronic 
e-cigarettes, and the potential exposure to e-liquids containing nicotine in high 
strength, may pose harm to public health. It is found to exert adverse effects on lung 
and brain development in addition to the other parts. Nicotine can also have a little 
effect on human haemodynamics [19] (Figure 3).
Compared to conventional cigarettes, similar substances with potential carci-
nogenic or toxic effects are found in aerosol from electronic cigarettes, but in lower 
concentrations, whereas emitted reactive oxygen radicals appear comparable [24]. 
Although males more commonly reported any type of tobacco use as well as e-cigs, 
9.5% of American high-school females reported current use of e-cigs, carrying 
a significant risk of using e-cigs in future pregnancies [25]. Although research is 
emerging around e-cigs in general, there continues to be a lack of scientific evidence 
regarding the safety and risks of e-cig use on maternal and fetal health, even though 
adverse health effects of nicotine on maternal and fetal outcomes are documented 
e-cigarettes, often touted as a safer alternative to cigarette smoking, may modify 
the DNA in the oral cells of users, potentially increasing the risk of cancer. Health 
risks conferred by smoking ordinary tobacco cigarettes include a number of non-
communicable diseases, such as chronic obstructive pulmonary disease (COPD), 
lung cancer and cardiovascular diseases (Figure 4).
The long-term effects of e-cigarette use are unknown. Improvements in lung 
function and pulmonary health have been demonstrated among smokers who 
have switched to e-cigarettes [26]. WHO [4] reported that ENDS use poses seri-
ous threats to adolescents and fetuses. It is also thought that nicotine can create an 
increased risk of sudden infant death syndrome (SIDS). Other adverse outcomes 
include disruptive behavioral disorders, attention deficit hyperactivity disorder, 
reduced respiratory compliance, forced expiratory flow, and impaired lung func-
tion. It is also thought that electronic cigarette use can expose individuals to 
oxidants. Some studies have associated electronic cigarette use with an increased 
oxidative stress [27]. Aside from toxicity, there are also risks from misuse or acci-
dents such as contact with liquid nicotine [28] (Figure 5).
Figure 3. 
Adverse effects of vaping on human health.
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e-Cigarette users who use e-cigarettes that contain nicotine are exposed to its 
potentially harmful effects [29]. Nicotine is associated with cardiovascular disease, 
potential birth defects, and poisoning. The vapor has been found to contain flavors, 
propylene glycol, glycerin, nicotine, tiny amounts of toxicants, carcinogens, heavy 
metals, and metal nanoparticles, and other harmful chemicals [19]. There is limited 
information available on the environmental issues around production, use, and 
disposal of e-cigarettes that use cartridges. Regulatory limits should be contem-
plated for levels of some of the more worrisome chemicals as well as for total flavor 
chemical levels.
Human and animal studies have found that nicotine exposure from e-cigarettes 
during adolescence adversely affects cognitive development [30], and animal 
research suggests that it has more severe impacts on the most vulnerable parts of the 
brain. One such region adversely affected by nicotine within the adolescent brain 
is the limbic system, which modulates drug reward, cognition, and emotion [31]. 
Nicotine is poisonous, and e-cigarette use or misuse can lead to nicotine poisoning 
via ingestion, inhalation, or absorption of nicotine via the skin or eyes. Early signs 
of accidental nicotine exposure include quickened tachycardia, diaphoresis, nausea, 
Figure 4. 
E-cigs—effect on the body parts.
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and vomiting, late effects include hypotension, hypoventilation and other effects 
include coma, seizure, respiratory, cardiac arrest and death.
As the usage of e-cigarettes increased between 2012 and 2015, the accidental 
nicotine exposure rate increased by 1398.2% in the US [32]. The absolute impact 
from passive exposure to EC vapor has the potential to lead to adverse health effects. 
The risk from being passively exposed to EC vapor is likely to be less than the risk 
from passive exposure to conventional cigarette smoke. Nicotine in tobacco smoke 
is absorbed into the bloodstream rapidly, and e-cigarette vapor is relatively slow in 
this regard [8]. e-Cigarettes have been advanced as a strategy to reduce the addic-
tive levels of nicotine in cigarettes. Nicotine, a key ingredient in most e-liquids, is a 
highly addictive substance. Nicotine stimulates regions of the cortex associated with 
reward, pleasure and reducing anxiety. When nicotine intake stops, withdrawal 
symptoms include cravings for nicotine, anger/irritability, anxiety, depression, 
impatience, trouble sleeping, restlessness, hunger or weight gain, and difficulty 
concentrating. During pregnancy, the nicotine exposure increases the risk for 
eclampsia, premature birth, still birth, reduced birth weight, reduced lung function 
at birth, apnea, cleft lip and palate and probably effects muscle and skeletal devel-
opment in the new-born child [33]. The nicotine content in e-cigarettes is adequate 
to cause or sustain nicotine dependence.
Systems toxicology investigations indicated that nicotine exposure also affected 
metabolic pathways the in liver, including upregulation of fatty acid beta-oxidation, 
cholesterol synthesis, gluconeogenesis, and ketone body formation pathways. Both 
standard and systems toxicology endpoints demonstrated very limited biologi-
cal effects of propyleneglycol (PG), and vegetable glycerin (VG) aerosol with no 
signs of toxicity. Systems toxicology analyses detected biological effects of nicotine 
exposure, which included up-regulation of the xenobiotic-metabolizing enzymes 
CYP1A1 and FMO3 in the lung and metabolic effects, likely interlinked with a 
generalized stress response to nicotine present in the exposure aerosols [34].
Because e-cigarettes are relatively new to the scene, yet a very little research 
is available about how they impact the body. Still, numerous studies already offer 
crucial insights about how vaping might affect both your risk of type two diabetes 
and your management of the disease. However, the safety of e-cigarettes is debated, 
and a growing body of evidence is suggesting several adverse health effects. It’s well 
known that traditional cigarettes can increase the risk of type two diabetes and 
related complications, but researchers are still analyzing the potential relationship 
between e-cigarettes and the disease.
Figure 5. 
Swithing to e-cigarettes—not a healthy choice.
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e-Cigarette use is associated with a 42% increased risk of myocardial infarc-
tion, or heart attack, for which people with diabetes already have a heightened risk. 
Smoking e-cigarettes can lead to the mobilization of cells called endothelial progen-
itor cells (EPCs) to damaged blood vessels, a reaction that also occurs after people 
smoke traditional cigarettes. Over time, repeated and chronic mobilization of 
EPCs can actually deplete them. Lower levels of EPCs are also associated with both 
cardiovascular disease and type two diabetes. The nicotine in e-cigarettes could 
also affect blood sugar followed by hemoglobin A1C to rise by 34% that indicate a 
higher risk of complications from diabetes, including eye disease, heart disease, and 
kidney disease [35].
Nicotine and cigarette smoking is known to promote weight loss and suppress 
appetite. Since becoming available in 2007, the use of electronic cigarettes (e-cig) 
has increased dramatically in the US, however there are still very few studies that 
examine the long-term consequences of e-vapor, particularly in the context of 
appetite regulation or weight management [36]. The marketing of e-cigarette 
use as a safer alternative to cigarette smoking has led to an increasing use even in 
pregnancy. The nicotine consumed by e-cigarettes is similar to that consumed by 
cigarette smoking. Animal studies confirm the dangers of nicotine to the developing 
fetus. More research needs to be done specifically assessing e-cigarette use, preg-
nancy, and pregnancy outcomes [37].
In vitro studies have shown that cytotoxic effects vary among EC refill fluids. A 
few flavored chemicals (such as cinnamaldehyde) have toxicity at the concentra-
tions used in EC [38], and stem cells are more sensitive than differentiated adult 
lung cells to EC products [39]. Recent studies have further shown that EC aerosols 
induced DNA strand breaks and reduced cell survival in vitro [40]. EC aerosols also 
reduced endothelial barrier function in cultured lung microvascular endothelial 
cells and increased inflammation and oxidative stress in mice [41]. Most case 
reports show that the health of children and adults can be negatively affected by 
EC products and that if death does not occur, negative effects can be reversed. Data 
further indicate that EC use can cause negative health effects in previously healthy 
individuals and exacerbate pre-existing conditions [42]. Research will help make 
electronic cigarettes more effective as smoking substitutes and will better define 
and further reduce residual risks from use to as low as possible, by establishing 
appropriate quality control and standards.
Mayer [43] suggested that the acute dose associated with a lethal outcome 
would be 500–1000 mg. Taking into account that voluminous vomiting is the first 
and characteristic symptom of nicotine ingestion, it seems that far higher levels of 
nicotine need to be ingested in order to have lethal consequences. However, due to 
the paucity of experimental data and contradictory evidence, it is difficult to draw 
conclusive outcomes regarding toxicological, immunological and clinical impacts 
of e-cig aerosols. Excessive vaping has been reported to induce inflammatory 
responses including mitogen-activated protein kinase, Janus tyrosine kinase/signal 
transducer and activator of transcription and nuclear factor-κB signaling, similar 
to that induced by tobacco smoke. Based on recent evidence, prolonged exposure to 
some constituents of e-cig aerosols might result in respiratory complications such as 
asthma, chronic obstructive pulmonary disease and inflammation.
A study using young healthy human airway epithelial cells showed that e-cigarette 
fluid promotes pro-inflammatory cytokine IL-6 production and human rhinovirus 
infection. Human lung fibroblasts exposed to e-cigarette liquid showed cell stress and 
other phenotypic abnormalities. A study in human embryonic stem cells also showed 
dysregulation of gene expression indicating a negative effect of e-cigarette use on 
heart development. Some studies found that at biologically relevant doses, vapor-
ized e-liquids induced increased DNA strand breaks and cell death, and decreased 
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clonogenic survival in both normal epithelial and head and neck squamous cell 
carcinoma cell lines independently of nicotine content [40]. Exposure to e-cigarette 
vapour also decreased the expression of cardiac transcription factors in cardiac 
progenitor cells, suggesting a persistent delay in differentiation [44].
Chemical 
constituents
Permissible 
limit
Toxic effect Molecular mechanism of 
toxicity
Reference
Acetaldehyde 45–270 ppm 
for 1 h
Eye, skin and respiratory 
tract irritation on acute 
exposure; pulmonary 
oedema and necrosis on 
higher exposures [46, 47]
Readily binds to protein and 
DNA, forming damaging 
adducts and impairing normal 
function and enzyme activity
[48, 49]
Acetone 750–
1000 ppm 
per 8 h
Respiratory irritant 
in small quantities; 
CNS depression and 
cardiorespiratory failure 
in large amounts [50, 51]
Metabolism in high amounts 
is not possible, leading to its 
accumulation and toxicity
[50]
Acrolein 0.1 ppm per 
8 h
Highly toxic respiratory 
and cardiovascular 
toxicant [51, 52]
Highly reactive, leading to 
DNA and protein adduction, 
endoplasmic reticulum 
stress, membrane damage, 
mitochondrial disruption, 
oxidative stress and immune 
dysfunction
[53]
Cadmium 5 μg m−3 of 
air for 8 h
Pulmonary changes with 
obstructive damage, 
renal dysfunction and 
teratogenicity in animals 
[54]
Interacts with DNA repair 
machinery, acts as a catalyst 
for ROS production, increases 
lipid peroxidation and induces 
apoptosis in cellular systems
[55, 56]
Chromium 0.5 mg m−3 Nasal ulcers and 
perforations, lung and 
prostate cancers [57]
Under physiological 
conditions, can produce 
reactive intermediates, 
hydrogen peroxide and GSH, 
which can attack DNA, protein 
and membrane lipids
[58]
Formaldehyde 0.3 ng m−3 Respiratory 
inflammation, 
pneumonia and 
bronchitis, neurological 
symptoms [57]
Highly reactive electrophilic 
reagent that can easily attach 
to neutrophilic biological 
targets, leading to formation of 
harmful adducts and ROS
[59]
Nicotine 0.5 mg m−3 Hypertension,
tachycardia, 
vasoconstriction, 
bronchorrhea, 
hyperpnoea [60, 61]
Toxicity attributed to oxidative 
damage, lipid peroxidation and 
DNA adduct formation
[62]
N-Nitrosamine 0.3 ng m−3 Carcinogen [57] Forms diazonium or oxynium 
ions which cause alkylating 
DNA
[63]
Toluene 200 ppm per 
8 h
Neurotoxicity including 
euphoria, depression, 
cognitive impairment [64]
Metabolises to form hippurate 
ions resulting in metabolic 
acidosis and hypokalaemia
[65]
Lead 50 μg m−3 
per 8 h
Neurotoxin, cardiotoxin, 
behavioral and 
developmental changes [66]
Causes oxidative stress and 
ionic imbalance
[67]
CNS, central nervous system; ROS, reactive oxygen species; GSH, glutathione.
Table 3. 
Chemical constituents of e-cigarettes and its molecular mechanism(s) of toxicity.
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Canistro et al. [45] found that e-cigs have a powerful booster effect on phase-I 
carcinogen-bioactivating enzymes, including activators of polycyclic aromatic 
hydrocarbons (PAHs), and increase oxygen free radical production and DNA oxida-
tion to 8-hydroxy2'-deoxyguanosine. Furthermore, we found that e-cigs damage 
DNA not only at chromosomal level in peripheral blood, such as strand breaks in 
leucocytes and micronuclei formation in reticulocytes, but also at gene level such 
as point mutations in urine. Despite its short comings, the work presented here 
strongly raises the possibility that e-cig consumption under certain conditions leads 
to toxicological outcomes directly and indirectly damaging DNA in the rat.
After e-cig aerosol exposure, the overall lipid composition of rat plasma was 
markedly affected with significant increases in the content of esterified cholesterol, 
total cholesterol and triglycerides. Also observed a significant increase in cytochrome 
P450 (CYP)-CYP1A1/2, CYP2B1/2 and CYP3A to an enhanced cancer risk from the 
widely bioactivated e-cig vapour procarcinogens associated with an increased risk of 
lung cancer with CYP induction and/or CYP polymorphisms (Table 3).
Three categories of negative health effects were identified: systemic effects, 
nicotine poisoning, and mechanical injury. Systemic effects include respiratory, 
gastrointestinal, cardiovascular, immunological and neurological systems. Patients 
with negative effects were experiencing symptoms such as shortness of breath 
and cough. For the individuals with bronchiolitis, acute eosinophilic pneumonia, 
and pneumonia with bilateral pleural effusions, the onset of adverse health effects 
occurred within 3–7 days of EC use. Dyspnea, productive cough, mild tachycardia, 
exogenous lipoid pneumonia. Bronchial syndrome associated with deterioration 
of pulmonary function test, sub-acute bronchial toxicity, pleuritic chest pain [68]. 
Relapsed medically refractive ulcerative colitis, abdominal distention, respira-
tory distress, isolated chronic necrotizing enterocolitis. Asymptomatic acute and 
paroxysmal atrial fibrillation (AF). Acute myocardial infarction. Reversible cerebral 
vasoconstriction syndrome. Nicotine poisoning effects involves accidental poison-
ing, poisoning caused by intentional abuse or misuse and suicidal attempts which 
are symptomized by sudden onset vomiting, irritability, tachycardia, flushing, 
salivation and nausea, dizziness, mild tremor, shivering, cardiovascular resuscita-
tion and full body seizures, multiple acute infarcts severe anoxic brain injury and 
death [69]. Mechanical injury caused by spontaneous explosion of EC battery. Also 
include oral trauma; tooth avulsion and severe mouth burns [70].
8. Harm reduction and safety
Awaiting future observations from current exposure must be taken into con-
sideration when assessing harmful effects of e-cigarettes, and a precautionary 
principle is highly relevant. e-Cigarettes can reduce smokers exposure to carcino-
gens and other toxic substances found in tobacco, and are very likely less harmful 
than tobacco cigarettes [71]. This is a motivation for many e-cigarette users. The 
American Association of Public Health Physicians (AAPHP) suggests those who 
are unwilling to quit tobacco smoking or unable to quit with medical advice and 
pharmaceutical methods should consider other nicotine containing products such 
as electronic cigarettes and smokeless tobacco for long term use instead of smoking. 
The safety of electronic cigarettes is uncertain [22]. Tobacco smoke contains 100 
known carcinogens, and 900 potentially cancer-causing chemicals, none of which 
has been found in more than trace quantities in e-cigarette vapor. A 2014 review 
recommended that regulations for e-cigarettes could be similar to those for dietary 
supplements or cosmetic products to not limit their potential for harm reduc-
tion [72]. A 2012 review found e-cigarettes could considerably reduce traditional 
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cigarettes use and they likely could be used as a lower risk replacement for tradi-
tional cigarettes, but there is not enough data on their safety and efficacy to draw 
definite conclusions.
9. Conclusions
Electronic cigarettes may help smokers stop their smoking, and the included 
studies did not find any serious side effects associated with their use for short 
duration up to 2 years. E-cigarettes are very limited and can be puzzling, so having 
the basic understanding of the mechanism of action, current regulation and health 
effects of this product. Impact on smoking cessation is unclear. Overall, the wide 
variability in products and lack of standardized testing methods makes evaluation 
of the available data in scientific community. It will be interesting to see the turn of 
events that e-cigarettes has in its role with tobacco users.
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